Earnings Call · Q4 FY2022·2023-03-16

Q4 22EPS +16.67%·Rev n/aQ3 22EPS -11.11%·Rev n/aQ2 22EPS +22.22%·Rev n/aQ1 22EPS +10.00%·Rev n/a⚠ consensus missing

GERON CORP GERN

Aron Feingold — Vice President of Investor Relations and Corporate Communications

John Scarlett — Chief Executive Officer

Faye Feller — Chief Medical Officer

Anil Kapur — Chief Commercial Officer

Olivia Bloom — Chief Financial Officer

−22.3%1d on move date−21.1% vs SPY3d−7.5%5d+3.4%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more GERN calls or request research access.

More GERN calls Browse calls Request research access